Inhibition of GEP-tumor growth by octreotide

Therapeutic Principles in the Management of Metastasising Carcinoid Tumors: Drugs for Symptomatic Treatment

“…As a consequence, there is an inhibition of gut motility, absorption, blood flow as well as endocrine and exocrine function. Octreotide controls effectively carcinoid syndrome including flushing, diarrhea and asthmatic at tacks [18]. Octreotide has also been found to be effective in the treatment of carcinoid crisis characterised by profound hypotension and tachycardia and should be available when the tumor patients undergo procedures that may precipi tate such crisis like surgery or radiologic intervention [19].…”